Product Document Searching Made Easy by 2D Code! | TCI Chemistry News November 2025 | [TCIPracticalExample] The Z-Selective Horner-Wadsworth-Emmons Reaction... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
请选择数量
CAS RN: 120202-66-6 | 产品编码: C2556
(S)-(+)-Clopidogrel Sulfate
| 产品编码 | C2556 |
纯度/分析方法
|
>98.0%(HPLC)(N) |
| 分子式/分子量 | C__1__6H__1__6ClNO__2S·H__2SO__4 = 419.89 |
| 外观与形状(20°C) | 固体 |
储存温度
|
冷藏 (0-10°C) |
| 应避免的情况 | 加热 |
包装和容器
|
1G-Glass Bottle with Plastic Insert (查看图片) |
| CAS RN | 120202-66-6 |
相关CAS RN
|
113665-84-2 |
| Reaxys-RN | 9967887 |
| PubChem物质ID | 125308051 |
| MDL编号 | MFCD00876395 |
技术规格
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Optical Isomer | max. 0.5 % |
| Purity(with Total Nitrogen) | min. 98.0 % |
| Specific rotation [a]20/D | +54.0 to +58.0 deg(C=1, MeOH) |
| NMR | confirm to structure |
物性(参考值)
| 比旋光度 [α]D | 56° (C=1,MeOH) |
| 溶解性(可溶于) | 甲醇 |
GHS
相关法规
运输信息
| HS编码* | 2934.99-000 |
应用
(S)-(+)-Clopidogrel Sulfate: An Antiplatelet Agent Acting as a P2Y12 ADP Receptor Antagonist
(S)-(+)-Clopidogrel sulfate is a thienopyridine class inhibitor of platelet activation and aggregation through the binding the P2Y12 class of adenosine diphosphate (ADP) receptors on platelets. (S)-(+)-Clopidogrel is must be metabolized by CYP450-2C19 enzymes in liver to produce the thiol active metabolite antagonizes binding irreversibly to the P2Y12 receptor and the subsequent ADP-mediated activation of the glycoprotein GPIIb/IIIa complex, thereby inhibiting platelet aggregation.1-4) On the other hand, the (R)-enantiomer has no antithrombotic activity.5) (S)-(+)-Clopidogrel has been often used in combination with acetylsalicylic acid (aspirin) [A2262] to the treatment of ischemic vascular disease.4) For your reference, [T2770] is a synthetic intermediate of (S)-(+)-clopidogrel. (The product is for research purpose only.)
References
- 1) P2Y12, a New Platelet ADP Receptor, Target of Clopidogrel
- 2) Identification of the platelet ADP receptor targeted by antithrombotic drugs
- 3) Clopidogrel: a review of its use in the prevention of thrombosis
- 4) Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
- 5) Developments in the synthesis of the antiplatelet and antithrombotic drug (S)-clopidogrel (a review)
PubMed Literature
技术文章
产品文档 (部分产品的分析图谱无法提供,敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注:该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉,您搜索的分析图谱无法提供。
